bpc 157 ovalo BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 — Evolved Science

After implantation, IGF-I is produced in the human embryo (37), but until then the source of IGF-I is thought to be the female reproductive tract, and it is known that the availability of the IGF-I ligand is important for blastocyst growth in human in vitro fertilization - IVF (38)

Nature Reviews Endocrinology, 9 (6), 357-365

The second is dose and route translation : even where an effect is real in a mouse, the human-equivalent dose is not a simple body-weight scaling, and as the route section above stressed there is no human bioavailability figure to anchor an oral-versus-injected comparison

There is so much happening